Study Finds New Insights in Young Adults Who Develop Myocarditis After COVID-19 Vaccination
The risk of severe COVID-19 continues to outweigh the rare risk of post-vaccination myocarditis.
Oral Insulin Is Delivered Successfully Via Rat Colons, Study Result Show
Analysis demonstrates that the tablets can significantly reduce the animals’ blood glucose levels for more than 5 hours.
Study: Eating Almonds Daily Boosts Recovery From Strenuous Exercise
Analysis shows 4-week daily dietary supplementation with the nuts increases the level of beneficial 12,13-DiHOME after physical activity.
Celebrate Your Colleagues on National Pharmacist Day 2023
Pharmacists report a myriad of reasons for joining the profession, including the connections they can build with patients.
Investigational T-cell Therapy for Viral Infections After Allogeneic Stem Cell Transplant Showed 95% Patient Response
Viral infections can plague patients who have undergone stem cell transplantation.
Patients With Inflammatory Disorders May Benefit From Psilocybin Treatment
Psilocybin is derived from certain types of mushrooms and has been proven to affect serotonin receptors.
Chronic Hepatitis B Patients in Africa Need Improved Diagnostic Tools, Study Results Show
Data are based on tests using low-cost, simple blood tests for helping decide which individuals with the disease need treatment.
FDA Approves Albuterol/Budesonide Rescue Medication for Asthma Exacerbations
The drug combination can significantly improve lung function and reduce severe asthma exacerbations.
Study Identifies Prevalence of Cardiac Amyloidosis Among Bone Scan Patients
Although cardiac amyloidosis was previously believed to be rare, more recent diagnostic advances and awareness have led to an increasing number of cases.
CDC Approves Mindfulness-Driven Digital Therapeutic for Diabetes Prevention
The new CDC-approved app launched January 1, 2023.
Tip of the Week: Learn Business Skills for the New Pharmacist
In querying pharmacists about what is required to be successful, many so-called “soft skills” in the social and administrative sciences rise to the top, but more evidence is needed.
Study Results Show Lower Mortality Risk With Nuplazid for Parkinson Disease Psychosis
Analysis indicates that Acadia Pharmaceuticals Inc’s pimavanserin is the only FDA-approved medication for the treatment of delusions and hallucinations associated with PDP.
Geron’s Imetelstat Demonstrates Positive Results in IMerge Phase 3 Trial for Lower-Risk MDS
Study meets primary and key secondary endpoints, showing clinically meaningful and statistically significant improvements.
A Review of Treatment Options, Guidelines for Heart Failure With Preserved Ejection Fraction
With the release of the 2022 AHA/ACC Guidelines for the Management of Heart Failure, patients with HFpEF now have a wider range of treatment options.
New Drug Delivery Method Could Replace Injections With Pills
The findings provide an alternative delivery strategy for peptide-based drugs and suggest that such techniques and principles could be applied to a broader range of drugs.
Vitamin D Supplementation Linked to Fewer Cases of Melanoma
In the geographical region of a recent study, data showed melanoma cause high mortality rates in relation to incidence.
Accelerate Time to Specialty Pharmacy Therapy with Digital Options
Digitizing hub processes can create an efficient and effective tech-driven patient access strategy speeding access to lifesaving therapies.
Depression Associated With Lower Medication Adherence Post-Percutaneous Coronary Intervention
Patients with depression were significantly less likely to have adequate 12-month adherence to antiplatelets, β-blockers, and statins than those without depression.
Study Evaluates Impact of CDI on Patients With Cystic Fibrosis
Patients with cystic fibrosis are typically administered antibiotics throughout their lives, which can increase the risk for C difficile infections.
Respiratory Syncytial Virus Vaccine Candidates Create Hope to Limit Global Infections
There are currently 33 RSV prevention candidates in clinical development using 6 different approaches.
Wearable Device Accurately Tracks Heart Failure Progression
Approximately half of patients with heart failure do not require an implantable monitoring device or do not qualify for thoracic monitoring.
FDA Approves FoundationOne Liquid CDx to Identify Genomic Profile in NSCLC
The biopsy test is the first companion diagnostic approved for entrectinib for individuals who do not have an available tissue sample.
Report Identifies 15 Key Drugs Predicted to Achieve Blockbuster Status by 2027
The report highlights the growth of personalized medicines with improved efficacy for rare, previously untreatable diseases.
Former CDC Director Discusses Public Health's Impact on National Policy
The first episode of the Public Health Matters Video Series features Tom Frieden, MPH, MD, who discusses his background and influence on public health and national policy.
Use of Telehealth Services for Mental Health Dramatically Increased in 2020, Offsetting Rapid Decline of In-Person Care
Individuals in metropolitan counties used mental health services more than individuals in rural counties.
Pain Management in Patients With Opioid Use Disorders
The chronic and excessive use of opioids has been associated with a wide range of psychosocial effects on the patient.
Differentiating Features of Atypical Hepatocellular Carcinoma vs Intrahepatic Mass-Forming Cholangiocarcinoma in Contrast-Enhanced MRI
Distinguishing between atypical hepatocellular carcinomas and intrahepatic cholangiocarcinoma can be difficult, but researchers identified several reliable MRI features to assist in differentiation.
Disparity Among Black, White Adults With Uncontrolled Blood Pressure
Black patients aged 18 to 49 years showed a greater association with uncontrolled blood pressure while on an antihypertensive medication.
Dapagliflozin Shows Safety, Efficacy in Heart Failure with Improved Ejection Fraction
A prespecified analysis of the DELIVER trial found the SGLT2 inhibitor dapagliflozin to benefit patients in a patient population previously excluded from heart failure outcomes trials.
FDA Grants Priority Review to Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma
If approved, glofitamab will treat the most aggressive type of non-Hodgkin lymphoma.
2 Clarke Drive Cranbury, NJ 08512